Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates
Background: ABO-incompatible (ABOi) kidney-transplantation has very good long-term results, i.e. similar to those observed for living-kidney ABO-compatible transplantation. This is because patients are desensitized at pretransplant using apheresis and rituximab therapy, with tacrolimus-based immunos...
Main Authors: | Lionel Rostaing, Asma Allal, Arnaud del Bello, Federico Sallusto, Laure Esposito, Nicolas Doumerc, Bénédicte Debiol, Audrey Delas, Xavier Game, Nassim Kamar |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2016-07-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/JNP-5-90.pdf |
Similar Items
-
Long-term outcomes after ABO-incompatible kidney transplantation; a single-center French study
by: Zhiyar Abdulrahman, et al.
Published: (2017-10-01) -
Immunoadsorption in ABO-incompatible kidney transplantation in adult and pediatric patients with follow-up on graft and patient survival: First series from India
by: Aseem Kumar Tiwari, et al.
Published: (2020-01-01) -
Non-antigen-specific Immunoadsorption Is a Risk Factor for Severe Postoperative Infections in ABO-Incompatible Kidney Transplant Recipients
by: Laura Matuschik, et al.
Published: (2024-03-01) -
ABO-incompatible kidney transplantation: Indian working group recommendations
by: A K Bhalla, et al.
Published: (2019-01-01) -
Emergency ABO-incompatible living donor liver transplantation in Wilson disease-induced acute liver failure
by: Joseph J Valamparampil, et al.
Published: (2023-01-01)